Editas Medicine, Inc. (EDIT)
2.46
-0.07
(-2.77%)
USD |
NASDAQ |
May 19, 16:00
2.47
+0.01
(+0.41%)
After-Hours: 20:00
Editas Medicine Profit Margin (Quarterly) : -882.4% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| Regeneron Pharmaceuticals, Inc. | 20.17% |
| Puma Biotechnology, Inc. | -8.37% |
| Black Diamond Therapeutics, Inc. | -- |
| X4 Pharmaceuticals, Inc. | -747.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -429.8% |
| Return on Assets | -53.84% |
| Return on Invested Capital | -117.6% |
| Gross Profit Margin (Quarterly) | 82.94% |
| Operating Margin (Quarterly) | -883.2% |
| Return on Net Operating Assets | -375.6% |